Sarcoidosis Immunotsuppressive Therapy and Lymphoma Development

Alexandria University

Status: Completed

Conditions: Sarcoidosis Lung

Treatments: Procedure: lymph node biopsy

Study type: Observational

Funder types: Other

Identifiers

NCT07343401

Alexandria U

Alexandria University

Details and patient eligibility

About

Impact of Immunosuppressive Therapy for Sarcoidosis on Lymphoma Development

Full description

This is a prospective observational cohort study to be conducted in the Chest Diseases Department, Alexandria Main University Hospital. A total of 40 adult patients (≥16 years) with biopsy-proven sarcoidosis will be consecutively recruited between December 2024 and December 2025. All patients will be either newly starting or continuing immunosuppressive therapy for sarcoidosis. The treatment regimen-systemic corticosteroids, conventional steroid-sparing agents (methotrexate, azathioprine, or mycophenolate), or biologics (anti-TNF agents)-will be recorded but not altered by study design. Each patient will be followed prospectively for 12 months from enrollment.

Enrollment: 40 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Inclusion criteria include adult patients (≥18 years) with histologically confirmed sarcoidosis, receiving or planned to receive immunosuppressive therapy

Exclusion Criteria:Patients with a prior history of lymphoma or other active malignancy, HIV infection, or other primary immunodeficiency will be excluded.

-

Trial design

40 participants in 1 patient group

Inclusion criteria include adult patients (≥16 years) with histologically confirmed sarcoidosis, rec

Description:

This is a prospective observational cohort study to be conducted in the Chest Diseases Department, Alexandria Main University Hospital. A total of 40 adult patients (≥16 years) with biopsy-proven sarcoidosis will be consecutively recruited between December 2024 and December 2025. All patients will be either newly starting or continuing immunosuppressive therapy for sarcoidosis.

Treatment:

Procedure: lymph node biopsy